Long-Term Prognostic Value of Albumin-Bilirubin Score at Discharge in Patients with Acute Heart Failure
Authors:
Open Access
- 29 November 2025
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 66 (6) , 956-960
Abstract
Liver dysfunction is associated with poorer outcomes in patients with heart failure (HF). The albumin-bilirubin (ALBI) score, which combines serum albumin and total bilirubin levels, has recently emerged as a useful tool to assess liver function and predict prognosis, yet its role in predicting long-term outcomes in patients with acute heart failure (AHF) remains unclear.A total of 492 patients with AHF who were admitted to our hospital were included in the study. The patients were divided into two groups based on their ALBI score at discharge: < -2.25 and ≥ -2.25. The primary endpoint was a composite of all-cause mortality and rehospitalization for HF.The mean age of the patients was 70 years, and 63% were male. During a median follow-up period of 189 days, patients with an ALBI score ≥ -2.25 had a significantly higher risk of the composite endpoint compared to those with an ALBI score < -2.25 (17.0% versus 7.4%, respectively; HR: 1.82, 95% CI: 1.34-2.49; P < 0.001). Multivariable Cox proportional hazards models confirmed that an ALBI score ≥ -2.25 was an independent predictor of poor outcomes, even after adjusting for factors related to HF (HR: 2.00, 95% CI: 1.29-3.13; P = 0.002).The ALBI score at discharge may be useful for risk stratification of all-cause mortality and rehospitalization for HF in patients with AHF.Keywords
This publication has 13 references indexed in Scilit:
- Clinical significance of the albumin–bilirubin score in patients with heart failure undergoing cardiac resynchronization therapyHeart and Vessels, 2022
- Clinical and Prognostic Values of ALBI Score in Patients With Acute Heart FailureHeart, Lung and Circulation, 2020
- Systolic blood pressure and cardiac mortality related to serum total bilirubin levels at admission in patients with acute heart failureHeart and Vessels, 2020
- Liver Function and Prognosis, and Influence of Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection FractionEuropean Journal of Heart Failure, 2020
- Organ Dysfunction, Injury and Failure in Acute Heart Failure: From Pathophysiology to Diagnosis and Management. A Review on Behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2017
- Abnormal Liver Function Tests in Acute Heart Failure: Relationship with Clinical Characteristics and Outcome in the PROTECT StudyEuropean Journal of Heart Failure, 2016
- Prognostic Value of Rising Serum Albumin During Hospitalization in Patients With Acute Heart FailureThe American Journal of Cardiology, 2016
- Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary dataAmerican Heart Journal, 2010
- Renal Impairment and Outcomes in Heart FailureJACC, 2006
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001